Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.57 USD
−8.07 M USD
41.09 M USD
29.39 M
About Equillium, Inc.
Sector
Industry
CEO
Bruce D. Steel
Website
Headquarters
La Jolla
Founded
2017
ISIN
US29446K1060
FIGI
BBG00LSL8C10
Equillium, Inc. is a clinical-stage biotechnology company that engages in the development of novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly in March 2017 and is headquartered in La Jolla, CA.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of EQ is 1.47 USD — it has decreased by −1.68% in the past 24 hours. Watch Equillium, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Equillium, Inc. stocks are traded under the ticker EQ.
EQ stock has risen by 2.45% compared to the previous week, the month change is a −23.30% fall, over the last year Equillium, Inc. has showed a 50.00% increase.
We've gathered analysts' opinions on Equillium, Inc. future price: according to them, EQ price has a max estimate of 4.00 USD and a min estimate of 4.00 USD. Watch EQ chart and read a more detailed Equillium, Inc. stock forecast: see what analysts think of Equillium, Inc. and suggest that you do with its stocks.
EQ stock is 5.67% volatile and has beta coefficient of −0.87. Track Equillium, Inc. stock price on the chart and check out the list of the most volatile stocks — is Equillium, Inc. there?
Today Equillium, Inc. has the market capitalization of 88.66 M, it has increased by 4.90% over the last week.
Yes, you can track Equillium, Inc. financials in yearly and quarterly reports right on TradingView.
Equillium, Inc. is going to release the next earnings report on Nov 18, 2025. Keep track of upcoming events with our Earnings Calendar.
EQ earnings for the last quarter are −0.16 USD per share, whereas the estimation was −0.23 USD resulting in a 30.43% surprise. The estimated earnings for the next quarter are −0.07 USD per share. See more details about Equillium, Inc. earnings.
Equillium, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
EQ net income for the last quarter is −5.74 M USD, while the quarter before that showed −8.65 M USD of net income which accounts for 33.68% change. Track more Equillium, Inc. financial stats to get the full picture.
No, EQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 9, 2025, the company has 35 employees. See our rating of the largest employees — is Equillium, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Equillium, Inc. EBITDA is −20.34 M USD, and current EBITDA margin is −19.79%. See more stats in Equillium, Inc. financial statements.
Like other stocks, EQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Equillium, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Equillium, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Equillium, Inc. stock shows the buy signal. See more of Equillium, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.